SYnAbs attended Buzz4Bio Cell&Gene Therapies

SYnAbs presented its unique one-stop-shop offer in CAR-T market from CAR design to anti-ScFv generation! Starting from patient leukapheresis - thanks to its partnership with EFS in France - SYnAbs is able to design custom rat or guinea pig mAb, create ScFv after mAb sequencing, design entire CAR structure, create HEK packaging cell lines and finally transfect T cells. Afterwards, SYnAbs apply its expertise in secondary monoclonal antibodies to create anti-ScFv and positively select transfected T cells.